Hypertension Pulmonary Secondary Heart Failure
1 clinical trials · Condition
◉ Watch Hypertension Pulmonary Secondary Heart Failure
| Record | Firm | Date |
|---|---|---|
| Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients (NCT03624010) | Tenax Therapeutics, Inc. | 2019-04-09 |
Track Hypertension Pulmonary Secondary Heart Failure automatically
Every clearance here is in the API, with alerts when new ones post.